Results
1 -
10 of
2050
(Click
here to explore results)
Drug Discovery for Psychiatric Disorders, CHAPTER 4 Glutamatergic Approaches for the Treatment of Schizophrenia . John A. Morrow, Robert Gilfillan, Stuart A. Neale
, 2012
, Pages 56-98
Amino Acids, Peptides and Proteins: Volume 35, Amino Acids . Weng C. Chan, Avril Higton, John S. Davies
, 2006
, Volume 35
, Pages 1-73
Capillary Electrophoresis–Mass Spectrometry for Metabolomics, CHAPTER 9 Potential of CE-MS for Chiral Metabolic Profiling . Elena Sánchez-López, María Luisa Marina, Antonio L. Crego
, 2018
, Pages 184-208
The Origin of Chirality in the Molecules of Life: From Awareness to the Current Theories and Perspectives of this Unsolved Problem (2), Chapter 5 Mechanisms of Amplification
, 2022
, Pages 104-148
The Origin of Chirality in the Molecules of Life: A Revision from Awareness to the Current Theories and Perspectives of this Unsolved Problem, Chapter 5 Mechanisms of Amplification
, 2009
, Pages 72-107
Drug Discovery for Schizophrenia, CHAPTER 6 Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia . Catharine A. Mielnik, Amy J. Ramsey
, 2015
, Pages 115-140
Drug Discovery for Schizophrenia, CHAPTER 7 Disrupted-in-Schizophrenia-1 (DISC1) Interactome and Schizophrenia . Tatiana V. Lipina, John C. Roder
, 2015
, Pages 141-172
Peptide-based Biomaterials, CHAPTER 6 The Use of d -Amino Acids for Peptide Self-assembled Systems . M. C. Cringoli, S. Marchesan
, 2021
, Pages 174-216
Amino Acids, Peptides and Proteins: Volume 15, Peptides with structural features not typical of proteins . J. H. Jones, P. M. Hardy
, 1984
, Volume 15
, Pages 370-413
Quantitative In Silico Chromatography: Computational Modelling of Molecular Interactions, CHAPTER 8 Enantioseparation
, 2014
, Pages 173-203